Deuterated etravirine
    7.
    发明授权

    公开(公告)号:US08410124B2

    公开(公告)日:2013-04-02

    申请号:US12288186

    申请日:2008-10-17

    申请人: Craig E. Masse

    发明人: Craig E. Masse

    IPC分类号: A61K31/505 C07D239/02

    CPC分类号: C07D239/48

    摘要: This disclosure relates to novel di-aryl-pyrimidine (DAPY) compounds and pharmaceutically acceptable salts thereof. This disclosure also provides compositions comprising a compound of this disclosure and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a non-nucleoside reverse transcriptase inhibitor (NNRTI).

    DEUTERATED 2-AMINO-3-HYDROXYPROPANOIC ACID DERIVATIVES
    8.
    发明申请
    DEUTERATED 2-AMINO-3-HYDROXYPROPANOIC ACID DERIVATIVES 有权
    去除2-氨基-3-羟基丙酸衍生物

    公开(公告)号:US20140221492A1

    公开(公告)日:2014-08-07

    申请号:US14220770

    申请日:2014-03-20

    申请人: Craig E. Masse

    发明人: Craig E. Masse

    IPC分类号: C07C235/34

    摘要: This invention relates to novel 2-amino-3-hydroxypropanoic acid derivatives and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering an NMDA glycine-site antagonist.

    摘要翻译: 本发明涉及新的2-氨基-3-羟基丙酸衍生物及其药学上可接受的盐。 本发明还提供了包含本发明化合物的组合物和这些组合物在治疗通过施用NMDA甘氨酸位点拮抗剂有益治疗的疾病和病症的方法中的用途。